Golden Grand

Golden Grand, primarily operating as Golden Grand (Beijing) Biotechnology Co., Ltd., is the specialized biotechnology and pharmaceutical division of Meihua Holdings Group. The company is a global leader in the industrial-scale production of high-purity amino acids, including L-Threonine, L-Lysine, and L-Valine, through advanced microbial fermentation and metabolic engineering. In addition to nutritional ingredients, Golden Grand's pharmaceutical arm, Hubei Golden Grand Pharmaceutical, manufactures key active pharmaceutical ingredients (APIs) such as Metformin and Gliclazide for the global metabolic health market. With extensive manufacturing facilities across China, the company integrates cutting-edge R&D with large-scale production to supply the pharmaceutical, food, and animal health industries. Golden Grand adheres to international quality standards, including GMP and ISO, ensuring its position as a reliable partner in the global life sciences supply chain.